{"id":4254,"date":"2024-11-28T19:36:03","date_gmt":"2024-11-28T08:36:03","guid":{"rendered":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/the-risks-of-cannabis-treatments-in-children-and-adolescents\/"},"modified":"2025-11-12T21:00:25","modified_gmt":"2025-11-12T10:00:25","slug":"the-risks-of-cannabis-treatments-in-children-and-adolescents","status":"publish","type":"post","link":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/the-risks-of-cannabis-treatments-in-children-and-adolescents\/","title":{"rendered":"The Risks of Cannabis Treatments in Children and Adolescents"},"content":{"rendered":"
 <\/div>\n

\"coverface\"The Vote 4 Medicine Debacle is a \u2018gift\u2019 that just keeps on giving!<\/em><\/strong><\/p>\n

The use of cannabinoids in medical treatments for children and adolescents is rising, often to manage conditions like epilepsy or chemotherapy-induced nausea. While this approach may seem promising, comprehensive research sheds light on the serious risks associated with these substances for young individuals.<\/p>\n

Increased Risk of Adverse Events: <\/strong>A detailed review of 23 clinical trials involving over 3,600 children and adolescents revealed significant risks linked to cannabinoid use. Compared to other treatments or placebos, these substances were associated with a higher likelihood of unpleasant side effects. Many participants experienced such severe adverse events that they withdrew from the studies altogether.<\/p>\n

For developing bodies, these risks are especially troubling. Symptoms like diarrhoea, extreme drowsiness, and signs of liver stress or damage were frequently reported, raising serious concerns about the impact on children\u2019s health.<\/p>\n

Concerns in Key Treatment Areas: <\/strong>Cannabinoids are often used as treatments for epilepsy and to manage chemotherapy-related nausea in children. However, the findings from the review call into question whether the potential benefits justify the heightened risks. Both conditions require effective relief, but exposing young, developing bodies to substances with such serious side effects demands caution and careful consideration.<\/p>\n

Long-Term Risks and Unanswered Questions: <\/strong>One of the major concerns highlighted by this research is the lack of information on the long-term effects of cannabinoids in younger individuals. Most trials only tracked participants for short periods, meaning the potential for chronic health impacts, dependency, or other developmental issues remains largely unknown.<\/p>\n

(For complete research J.A.M.A<\/a><\/strong>)<\/p>\n

Also see <\/p>\n